Indicators

Markets:

News

Latest News about RGEN

Recent news which mentions RGEN

< Previous 1 2 3 4 5 Next >

This Foreboding Sign Looms Over Repligen's Chart

February 02, 2022

2 Healthcare Stocks That Could Help Set You Up for Life

January 20, 2022

These Are 5 of the Fastest-Growing Large-Cap Stocks on the Planet

January 13, 2022

Repligen Corp (RGEN) Q3 2021 Earnings Call Transcript

October 28, 2021

The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug

October 28, 2021

Earnings Scheduled For October 28, 2021

October 28, 2021

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More

October 24, 2021

NIO Stock Is Very Richly Valued, But I Can See Why It Tempts People

October 19, 2021

2 Tricks and a Treat for Gene Therapy Investors

October 18, 2021

Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021

October 14, 2021

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug

September 30, 2021

The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data

September 23, 2021

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs

September 22, 2021

3 Unstoppable Healthcare Stocks to Buy With Just $1,000

September 22, 2021

Great Performers That Are Still Great Stocks

September 21, 2021

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data

September 21, 2021

10 Biggest Price Target Changes For Friday

September 17, 2021

The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold

September 17, 2021

Repligen Reinforces Proteins Business With $150M Avitide Acquisition Deal

September 16, 2021

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study

September 16, 2021

Chief Executive Officer Of Repligen Trades $8.18 Million In Company Stock

September 14, 2021

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod

September 08, 2021

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself

September 03, 2021

Repligen Senior VP Makes $1.13 Million Sell

September 02, 2021

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab

September 02, 2021

The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering

September 01, 2021

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical

August 31, 2021

Stocks That Hit 52-Week Highs On Friday

August 27, 2021

The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration

August 27, 2021

The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO

August 26, 2021

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.